What does a low TC/HDL ratio indicate?

A low TC/HDL ratio (below 3.5) indicates excellent cardiovascular health and reduced heart disease risk. This favorable ratio means you have high levels of protective HDL cholesterol relative to your total cholesterol, which helps remove excess cholesterol from arteries.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the TC/HDL Ratio

The total cholesterol to HDL cholesterol ratio (TC/HDL) is one of the most powerful predictors of cardiovascular disease risk. This simple calculation divides your total cholesterol by your HDL (high-density lipoprotein) cholesterol, providing insight into how well your body manages cholesterol transport and removal.

HDL cholesterol, often called "good cholesterol," acts like a cleanup crew in your bloodstream. It removes excess cholesterol from your arteries and transports it back to your liver for disposal. When you have a low TC/HDL ratio, it means you have relatively high levels of this protective HDL compared to your total cholesterol—a sign of excellent cardiovascular health.

How to Calculate Your TC/HDL Ratio

Calculating your TC/HDL ratio is straightforward. Simply divide your total cholesterol by your HDL cholesterol. For example, if your total cholesterol is 180 mg/dL and your HDL is 60 mg/dL, your ratio would be 3.0 (180 ÷ 60 = 3.0).

TC/HDL Ratio Risk Categories

Risk categories based on American Heart Association guidelines and cardiovascular outcome studies.
TC/HDL RatioRisk CategoryInterpretationRecommended Action
Below 3.0Below 3.0OptimalExcellent cardiovascular protectionMaintain healthy lifestyle
3.0-3.53.0-3.5Low RiskGood cardiovascular healthContinue preventive measures
3.5-5.03.5-5.0Average RiskModerate cardiovascular riskConsider lifestyle improvements
Above 5.0Above 5.0High RiskElevated cardiovascular riskConsult healthcare provider

Risk categories based on American Heart Association guidelines and cardiovascular outcome studies.

Understanding your cholesterol ratios and other cardiovascular markers through regular testing can help you track your heart health progress over time.

What Is Considered a Low TC/HDL Ratio?

Medical professionals consider different TC/HDL ratio ranges when assessing cardiovascular risk. Understanding where your ratio falls can help you and your healthcare provider make informed decisions about your heart health.

A TC/HDL ratio below 3.5 is considered optimal and indicates low cardiovascular risk. Ratios between 3.5 and 5.0 suggest average risk, while ratios above 5.0 indicate higher risk. Some research suggests that ratios below 3.0 provide even greater cardiovascular protection, particularly in women.

Gender Differences in TC/HDL Ratios

Women typically have higher HDL cholesterol levels than men, which often results in lower TC/HDL ratios. Premenopausal women usually maintain ratios below 3.5, while men of the same age often have ratios between 4.0 and 5.0. After menopause, women's HDL levels may decrease, potentially increasing their TC/HDL ratio.

Health Benefits of a Low TC/HDL Ratio

Maintaining a low TC/HDL ratio provides numerous cardiovascular benefits. Research consistently shows that people with lower ratios have significantly reduced risk of heart disease, stroke, and other cardiovascular events.

Reduced Atherosclerosis Risk

A low TC/HDL ratio indicates efficient cholesterol removal from arterial walls. High HDL levels actively reverse cholesterol transport, pulling cholesterol out of developing plaques and reducing atherosclerosis progression. Studies show that for every 1-point decrease in the TC/HDL ratio, cardiovascular risk drops by approximately 20-25%.

Better Metabolic Health

People with low TC/HDL ratios often have better overall metabolic health. This includes improved insulin sensitivity, lower inflammation markers, and reduced risk of metabolic syndrome. The relationship between HDL and metabolic health is bidirectional—good metabolic health promotes higher HDL, and higher HDL supports better metabolic function.

Enhanced Longevity

Population studies have found strong associations between low TC/HDL ratios and increased lifespan. The Framingham Heart Study, which followed participants for decades, showed that individuals maintaining TC/HDL ratios below 3.5 had significantly longer life expectancies and fewer cardiovascular events compared to those with higher ratios.

Factors That Contribute to a Low TC/HDL Ratio

Several lifestyle and genetic factors influence your TC/HDL ratio. Understanding these factors can help you maintain or achieve a healthier ratio.

  • Regular aerobic exercise (increases HDL by 5-10%)
  • Mediterranean diet rich in olive oil and omega-3 fatty acids
  • Moderate alcohol consumption (though this isn't recommended as a strategy)
  • Not smoking (smoking lowers HDL by up to 15%)
  • Maintaining a healthy weight
  • Managing stress effectively
  • Genetic factors (some people naturally produce more HDL)

Regular monitoring of your lipid profile, including advanced markers like ApoB and ApoA1, can provide deeper insights into your cardiovascular health beyond traditional cholesterol measurements.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When a Low TC/HDL Ratio Might Need Further Investigation

While a low TC/HDL ratio is generally positive, extremely low total cholesterol (below 120 mg/dL) combined with very high HDL can occasionally indicate underlying conditions that warrant investigation.

Genetic Hyperalphalipoproteinemia

Some individuals have genetic variants that cause extremely high HDL levels (above 100 mg/dL). While this often provides cardiovascular protection, certain genetic forms may not offer the expected benefits. Genetic testing and advanced lipid analysis can help determine if high HDL is truly protective.

Secondary Causes of High HDL

Certain medications, excessive alcohol consumption, and some autoimmune conditions can artificially elevate HDL levels. If your HDL is unusually high (above 80 mg/dL in men or 100 mg/dL in women), your healthcare provider may investigate these secondary causes.

How to Maintain a Healthy TC/HDL Ratio

Maintaining a low TC/HDL ratio requires a comprehensive approach to cardiovascular health. Here are evidence-based strategies to optimize your ratio:

Dietary Strategies

  • Increase omega-3 fatty acids from fish, walnuts, and flaxseeds
  • Replace saturated fats with monounsaturated fats from olive oil and avocados
  • Consume 25-35 grams of fiber daily from whole grains, legumes, and vegetables
  • Include plant sterols from nuts and seeds
  • Limit trans fats and processed foods
  • Consider adding niacin-rich foods like turkey, chicken, and mushrooms

Exercise Recommendations

Aerobic exercise is particularly effective at raising HDL cholesterol. Aim for at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic exercise weekly. High-intensity interval training (HIIT) has shown particular promise in improving HDL levels and the TC/HDL ratio.

Lifestyle Modifications

Beyond diet and exercise, several lifestyle factors significantly impact your TC/HDL ratio. Quitting smoking can increase HDL by 15-20% within weeks. Managing stress through meditation, yoga, or other relaxation techniques helps maintain healthy cholesterol levels. Adequate sleep (7-9 hours nightly) supports optimal lipid metabolism.

Monitoring Your TC/HDL Ratio Over Time

Regular monitoring helps track your cardiovascular health progress and the effectiveness of lifestyle interventions. Most experts recommend checking your lipid panel annually if your ratios are optimal, or every 3-6 months if you're actively working to improve them.

When reviewing your results, look for trends rather than focusing on single measurements. HDL levels can fluctuate based on recent exercise, diet, and even the time of day. Tracking your TC/HDL ratio alongside other cardiovascular markers provides a more complete picture of your heart health.

The Bottom Line on Low TC/HDL Ratios

A low TC/HDL ratio is one of the best indicators of cardiovascular health you can have. It suggests your body efficiently manages cholesterol, removing excess amounts from your arteries and reducing your risk of heart disease. While genetics play a role, most people can improve their TC/HDL ratio through lifestyle modifications including regular exercise, a heart-healthy diet, and avoiding smoking.

Remember that the TC/HDL ratio is just one piece of the cardiovascular puzzle. Comprehensive assessment including other lipid markers, inflammatory indicators, and metabolic health markers provides the most complete picture of your cardiovascular risk. Work with your healthcare provider to interpret your results in the context of your overall health and develop a personalized plan for maintaining optimal cardiovascular health.

References

  1. Millán, J., Pintó, X., Muñoz, A., Zúñiga, M., Rubiés-Prat, J., Pallardo, L. F., ... & Pedro-Botet, J. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Lemieux, I., Lamarche, B., Couillard, C., Pascot, A., Cantin, B., Bergeron, J., ... & Després, J. P. (2001). Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. Archives of Internal Medicine, 161(22), 2685-2692.[PubMed][DOI]
  3. Castelli, W. P., Abbott, R. D., & McNamara, P. M. (1983). Summary estimates of cholesterol used to predict coronary heart disease. Circulation, 67(4), 730-734.[PubMed][DOI]
  4. Calling, S., Johansson, S. E., Wolff, M., Sundquist, J., & Sundquist, K. (2021). Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden. BMC Cardiovascular Disorders, 21(1), 163.[PubMed][DOI]
  5. Arsenault, B. J., Rana, J. S., Stroes, E. S., Després, J. P., Shah, P. K., Kastelein, J. J., ... & Khaw, K. T. (2009). Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology, 55(1), 35-41.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my TC/HDL ratio at home?

You can test your TC/HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes total cholesterol and HDL cholesterol testing along with other important cardiovascular markers. The program provides CLIA-certified lab results from a simple at-home blood draw.

What is the ideal TC/HDL ratio?

The ideal TC/HDL ratio is below 3.5, with ratios below 3.0 offering even greater cardiovascular protection. Women typically have lower ratios than men due to naturally higher HDL levels.

Can I have a TC/HDL ratio that's too low?

While rare, extremely low ratios (below 2.0) combined with very high HDL (above 100 mg/dL) may warrant investigation for genetic conditions or secondary causes. Most people benefit from lower ratios.

How quickly can I improve my TC/HDL ratio?

With lifestyle changes like regular exercise and dietary improvements, you can see improvements in your TC/HDL ratio within 6-12 weeks. HDL typically responds more slowly than other cholesterol markers, so consistency is key.

Does the TC/HDL ratio matter more than LDL cholesterol?

Both markers are important. The TC/HDL ratio is a powerful predictor of cardiovascular risk, sometimes even more so than LDL alone. However, comprehensive cardiovascular assessment should include multiple markers for the most accurate risk assessment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details